Lineage Cell Therapeutics, Inc. (TLV:LCTX)
Israel
· Delayed Price · Currency is ILS · Price in ILA 164.20
-4.10 (-2.44%)
May 13, 2025, 5:24 PM IDT
Lineage Cell Therapeutics Market Cap
Lineage Cell Therapeutics has a market cap or net worth of 390.95 million as of May 13, 2025. Its market cap has decreased by -50.90% in one year.
Market Cap
390.95M
Enterprise Value
224.21M
Revenue
34.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
164.20
Market Cap Chart
Since May 1, 1992, Lineage Cell Therapeutics's market cap has increased from 49.45M to 390.95M, an increase of 690.60%. That is a compound annual growth rate of 6.46%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 73.61B |
| Danel (Adir Yeoshua) | 2.35B |
| Kamada | 1.39B |
| Bait Bakfar | 1.15B |
| Novolog (Pharm-Up 1966) | 779.55M |
| SofWave Medical | 722.24M |
| Ilex Medical | 680.80M |
| BrainsWay | 586.43M |